Results 201 to 210 of about 39,275 (210)

The GLP-1 Receptor Agonist Revolution

JACC
Stephen J. Nicholls, Adam J. Nelson
openaire   +1 more source

Pharmacological profile of lixisenatide: A new GLP-1 receptor agonist for the treatment of type 2 diabetes

Regulatory Peptides, 2010
exaly  

GLP-1 receptor agonists in rheumatic disease

The Lancet Rheumatology
openaire   +2 more sources

Risk of major adverse cardiovascular events and stroke associated with treatment with GLP-1 or the dual GIP/GLP-1 receptor agonist tirzepatide for type 2 diabetes: A systematic review and meta-analysis

European Stroke Journal
Maria-Ioanna Stefanou, Aikaterini Theodorou, Konark Malhotra   +2 more
exaly  

GLP-1 receptor agonist tachyphylaxis and perioperative recommendations

British Journal of Anaesthesia
Fei Wu, Seth A. Klapman, Lucinda L. Everett, Braden Kuo, Ion A. Hobai   +4 more
openaire   +2 more sources

Efficacy of GLP‐1 Receptor Agonist‐Based Therapies on Cardiovascular Events and Cardiometabolic Parameters in Obese Individuals Without Diabetes: A Meta‐Analysis of Randomized Controlled Trials

Journal of Diabetes
Jieli Lu, Yuhong Chen
exaly  

Perioperative GLP-1 Receptor Agonists

Bradshaw, Brad, Kloosterboer, Amy
openaire   +1 more source

Healthy weight loss maintenance with exercise, GLP-1 receptor agonist, or both combined followed by one year without treatment: a post-treatment analysis of a randomised placebo-controlled trial

EClinicalMedicine
Simon Birk Kjær Jensen, Christian R Juhl, Charlotte Janus   +2 more
exaly  

GLP-1 Receptor Agonists and Perioperative Care: Reply

Anesthesiology
Girish P. Joshi, Teresa LaMasters, Tammy L. Kindel   +2 more
openaire   +2 more sources

Safety, tolerability, pharmacokinetics, and pharmacodynamics of the first-in-class GLP-1 and amylin receptor agonist, amycretin: a first-in-human, phase 1, double-blind, randomised, placebo-controlled trial

Lancet, The
exaly